K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary

被引:27
作者
Alvarez, AA [1 ]
Moore, WF
Robboy, SJ
Bentley, RC
Gumbs, C
Futreal, PA
Berchuck, A
机构
[1] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA
关键词
Mullerian inclusion cyst; serous borderline ovarian tumor; K-ras;
D O I
10.1006/gyno.2000.6066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Mullerian inclusion cysts (MIC) are small benign appearing glands that are occasionally noted in lymph nodes and peritoneal biopsies. They occur most frequently in women with serous ovarian tumors, with borderline tumors (SBOT) having a higher incidence than invasive cancers. The aim of this study was to examine whether MIC and SBOT have identical K-ras mutations, which would suggest that they are related. Methods. Six patients in whom adequate tissue was available from SBOT, MIC, and normal tissue were identified from a consecutive series of patients with SBOT who underwent lymph node sampling from 1992 to 1997 at Duke University Medical Center. DNA extraction was performed using laser capture microdissection. Exon 1 of the K-ras gene was amplified using PCR and subjected to single-strand conformation analysis to screen for mutations. Shifted bands were sequenced to confirm the presence of mutations. Results. Mutations in codon 12 of K-ras were found in three of six (50%) SBOT. In two of these three cases, the identical mutation was found in the SBOT and the MIC (gly to val in both cases), but not in the corresponding normal DNA. In one case, a mutation was seen in the ovarian tumor (gly to asp), but not in the corresponding MIC. Conclusions. Mutations in codon 12 of the K-ras gene are a hallmark of serous borderline tumors. The presence of identical K-ras mutations in some SBOT and their associated MIC suggests that they are related processes. Both may arise due to a field effect, or alternatively some MIC may represent metastases from the primary ovarian tumor. (C) 2001 Academic Press.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 26 条
[1]   Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors [J].
Caduff, RF ;
Svoboda-Newman, SM ;
Ferguson, AW ;
Johnston, CN ;
Frank, TS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (03) :323-328
[2]  
EHRMANN RL, 1980, AM J OBSTET GYNECOL, V136, P737, DOI 10.1016/0002-9378(80)90450-0
[3]   FREQUENCY AND HISTOGENESIS OF PELVINE RETROPERITONEAL LYMPH-NODE INCLUSIONS OF THE FEMALE GENITAL-TRACT - AN IMMUNOHISTOCHEMICAL STUDY OF 34 CASES [J].
HORN, LC ;
BILEK, K .
PATHOLOGY RESEARCH AND PRACTICE, 1995, 191 (10) :991-996
[4]  
HSU YK, 1980, OBSTET GYNECOL, V55, P83
[5]   CLONAL ORIGIN OF EPITHELIAL OVARIAN-CARCINOMA - ANALYSIS BY LOSS OF HETEROZYGOSITY, P53-MUTATION, AND X-CHROMOSOME INACTIVATION [J].
JACOBS, IJ ;
KOHLER, MF ;
WISEMAN, RW ;
MARKS, JR ;
WHITAKER, R ;
KERNS, BAJ ;
HUMPHREY, P ;
BERCHUCK, A ;
PONDER, BAJ ;
BAST, RC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (23) :1793-1798
[6]   POSSIBLE METAPLASTIC ORIGIN OF LYMPH-NODE METASTASES IN SEROUS OVARIAN TUMOR OF LOW MALIGNANT POTENTIAL (BORDERLINE SEROUS TUMOR) [J].
KADAR, N ;
KRUMERMAN, M .
GYNECOLOGIC ONCOLOGY, 1995, 59 (03) :394-397
[7]  
KARP LA, 1969, AM J CLIN PATHOL, V52, P212
[8]  
Kupryjanczyk J, 1996, MODERN PATHOL, V9, P166
[9]   P53 GENE ANALYSIS OF OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS [J].
KUPRYJANCZYK, J ;
BELL, DA ;
DIMEO, D ;
BEAUCHAMP, R ;
THOR, AD ;
YANDELL, DW .
HUMAN PATHOLOGY, 1995, 26 (04) :387-392
[10]   NONINVASIVE OVARIAN-CARCINOMA [J].
LAUCHLAN, SC .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1990, 9 (02) :158-169